We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SKBN:TASEShikun & Binui Ltd. Analysis

Data as of 2026-03-14 - not real-time

ILA 1,766.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock trades at 1,766 ILA, sitting just above the computed support of 1,636 and below resistance 1,975. Technicals show a bullish MACD histogram (+2.25) and an RSI of 43, indicating neutral momentum with a slight upside bias. Volume is increasing and the market sentiment index is in "Greed" territory (72.9), suggesting short‑term buying pressure. However, fundamentals are weak: a negative profit margin of –4.1%, operating cash flow of –340 M ILA, and free cash flow of –1.68 B ILA signal earnings pressure. The balance sheet is heavily leveraged, with a debt‑to‑equity ratio of 254 and a price‑to‑book of 239, far above the industry norm. The forward P/E of 30.98 is only marginally above the sector average of 29.1, offering little valuation cushion.
Recent news of a 71 MW solar project under the DeepSolar SaaS platform hints at potential growth in the renewable‑energy segment. Yet, the company does not pay a dividend, and its ROE is –9.3%, underscoring capital‑return challenges. High 30‑day volatility (43%) and a low beta (0.46) indicate price swings that are not strongly correlated with the market. Given the overvalued P/B, substantial debt burden, and negative cash generation, the stock appears overvalued from a value‑investor perspective. The blend of modest growth prospects and distressed fundamentals leads to a cautious stance. Investors should weigh the short‑term technical upside against the long‑term structural risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram and increasing volume
  • Price above near‑term support level
  • Market sentiment in Greed zone

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • 71 MW solar project indicating potential revenue growth
  • Forward P/E roughly aligned with industry
  • Continued high leverage and negative cash flow

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Extremely high debt‑to‑equity ratio and negative ROE
  • Overinflated price‑to‑book multiple
  • Persistent negative operating and free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth6.20%
Profit Margin-4.14%
P/E Ratio31.0
ROE-9.35%
ROA-0.33%
Debt/Equity253.93
P/B Ratio239.0
Op. Cash FlowILA-340000000
Free Cash FlowILA-1682125056
Industry P/E29.1

Technical Analysis

TrendNeutral
RSI43.2
SupportILA 1,636.00
ResistanceILA 1,975.00
MA 20ILA 1,818.30
MA 50ILA 1,889.76
MA 200ILA 1,607.11
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

GradeOvervalued
TypeBlend

Risk Assessment

Beta0.46
Volatility43.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.